| SCHEDULE OF ACCRUED EXPENSES AND OTHER LIABILITIES |
SCHEDULE
OF ACCRUED EXPENSES AND OTHER LIABILITIES
| | |
September
30,
2023 | | |
December
31,
2022 | |
| Accrued research and development | |
$ | 500,197 | | |
$ | 1,332,713 | |
| Share subscription facility commitment fees | |
| - | | |
| 400,000 | |
| Professional fees | |
| 164,100 | | |
| 421,530 | |
| Other accrued liabilities | |
| 96,161 | | |
| 72,251 | |
| Total accrued expenses
and other liabilities | |
$ | 760,458 | | |
$ | 2,226,494 | |
|
Accrued
expenses and other liabilities consisted of the following:
SCHEDULE OF ACCRUED EXPENSES AND OTHER LIABILITIES
| | |
2022 | | |
2021 | |
| | |
December 31, | |
| | |
2022 | | |
2021 | |
| Accrued research and development | |
$ | 1,332,713 | | |
$ | 388,997 | |
| Share subscription facility commitment fees | |
| 400,000 | | |
| 800,000 | |
| Professional fees | |
| 421,530 | | |
| 138,086 | |
| Other accrued liabilities | |
| 72,251 | | |
| 67,939 | |
| Accrued scientific advisory board fees | |
| - | | |
| 60,032 | |
| Consultant fees | |
| - | | |
| 1,342,479 | |
| Bonus Accrual | |
| - | | |
| 610,000 | |
| Total accrued expenses and other liabilities | |
$ | 2,226,494 | | |
$ | 3,407,533 | |
|
| SCHEDULE OF OTHER LONG-TERM LIABILITIES |
|
Other
long-term liabilities consisted of the following:
SCHEDULE OF OTHER LONG-TERM LIABILITIES
| | |
2022 | | |
2021 | |
| | |
December 31, | |
| | |
2022 | | |
2021 | |
| Share subscription facility commitment fees | |
$ | - | | |
$ | 349,202 | |
| Liability classified warrants | |
| 310,346 | | |
| 3,303,588 | |
| Total other long-term liabilities | |
$ | 310,346 | | |
$ | 3,652,790 | |
| Other
long-term liabilities | |
$ | 310,346 | | |
$ | 3,652,790 | |
|